PRE Prenetics Global Limited

NASDAQ
$25.44

Prenetics Global Limited (PRE) is expected to report earnings on November 17, 2026, before the market open. The consensus earnings estimate is a loss of $0.73 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +29.8% since its last earnings release on August 18, 2026.

Prenetics Global Limited Missed Consensus Estimates, Raises Guidance
Tuesday, August 18, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 17
Tuesday · 7:30 AM ET
Earnings Whisper
-
vs ($0.73)
Rev est $63.6M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $24.16

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Prenetics Global Limited

Prenetics is a major global diagnostics and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Prevention, Diagnostics and Personalized Care — comprehensive and accessible to anyone, at anytime and anywhere.

Sector

Healthcare

Industry

Biotechnology